MA-SFM is an efficient and successful method of detecting RAPD

Article

Swinging flashlight test modified with magnification (MA-SFM) is an efficient way of detecting relative afferent papillary defect (RAPD).

Swinging flashlight test modified with magnification (MA-SFM) is an efficient way of detecting relative afferent papillary defect (RAPD), states an investigation in the Journal of Glaucoma.

Dr Parul Ichhpujani et al., Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India, performed a prospective, observational study of 101 consecutive patients. This study group consisted of 68 diagnosed glaucoma patients, 20 glaucoma suspects and 13 controls. All participants were screened for RAPD presence of absence. This was completed by using either the standard swinging flashlight method (S-SFM), MA-SFM or the ophthalmoscope swinging flashlight method.

Humphrey visual field mean deviation (MD) in each eye, intereye differences in MD, disc damage likelihood score (DDLS) and intereye differences in DDLS were all measured. Weighted κ scores were also recorded to ensure agreement between tests.

The most sensitive method for identifying RAPD is MA-SFM for both intereye differences in DDLS and MD. There was significant agreement between the tests for the MA-SFM method and moderate to significant agreement between the observers. The study suggests that using MA-SFM for detecting RAPD is a low-cost, simple and reproducible method.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.